Gavin MacBeath
Chief Executive Officer at TSCAN THERAPEUTICS, INC.
Net worth: 395 150 $ as of 2024-03-30
Profile
Gavin MacBeath was the founder of Merrimack Pharmaceuticals, Inc. (founded in 1993) where he held the title of Senior Director & Head-Translational Research from 2011 to 2012.
He is currently the Chief Executive Officer & Director at TScan Therapeutics, Inc. since 2018.
Previously, he was the Chief Scientific Officer at Abpro Corp.
from 2017 to 2018 and an Associate Professor at Harvard University from 2002 to 2010.
Dr. MacBeath obtained his doctorate degree from The Scripps Research Institute in 1997 and his undergraduate degree from the University of Manitoba in 1991.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TSCAN THERAPEUTICS, INC.
0.11% | 2023-06-12 | 49,767 ( 0.11% ) | 395 150 $ | 2024-03-30 |
Gavin MacBeath active positions
| Companies | Position | Start |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Chief Executive Officer | 2023-03-27 |
Former positions of Gavin MacBeath
| Companies | Position | End |
|---|---|---|
| ABPRO CORPORATION | Chief Tech/Sci/R&D Officer | 2018-06-30 |
| MERRIMACK PHARMACEUTICALS, INC. | Founder | 2017-08-31 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2010-05-31 |
Training of Gavin MacBeath
| The Scripps Research Institute | Doctorate Degree |
| University of Manitoba | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
- Stock Market
- Insiders
- Gavin MacBeath
